2012

1. Systemic anticancer agents: Dermatologic indications and adverse events

   Comprehensive Dermatologic Drug Therapy: Expert Consult - Online and Print (Elsevier), pp. 397-407

2. The risk of skin rash and stomatitis with the mammalian target of rapamycin inhibitor temsirolimus: A systematic review of the literature and meta-analysis

   European Journal of Cancer, Vol. 48, Núm. 3, pp. 340-346